Hydrogel-embedded endothelial progenitor cells evade LPS and mitigate endotoxemia

American Journal of Physiology - Renal Physiology

Volumn 301, Issue 4, 2011, Pages

  Ghaly, T ^a   Rabadi, May M ^a   Weber, Mia ^a   Rabadi, Seham M ^a   Bank, Michael ^a   Grom, John M ^a   Fallon, John T ^a   Goligorsky, Michael S ^a   Ratliff, Brian B ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Lipopolysaccharide; Microcirculation; Renal function; Sepsis; Stem cell therapy

Indexed keywords

CELL PROTEIN; CREATININE; HYALURONIC ACID; HYALURONIDASE; LIPOPOLYSACCHARIDE; PRONECTIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CELL PROTECTION; CELL THERAPY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOTHELIAL PROGENITOR CELL; ENDOTOXEMIA; FIBROSIS; FLUORESCENCE ACTIVATED CELL SORTING; HYDROGEL; IMMUNOCYTOCHEMISTRY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LASER DOPPLER FLOWMETRY; LIVER CELL DAMAGE; MICROCIRCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 80053350848     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00124.2011     Document Type: Article

References (46)

1. Aird WC. The role of endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101: 3765-3777, 2003.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310, 2001.
3. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. VEGF contributes to postnatal neovascularizaiton by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18: 3964-3972, 1999.
4. Becchi C, Pillozzi S, Fabbri LP, Al Malyan M, Cacciapuoti C, Della Bella C, Nucera M, Masselli M, Boncinelli S, Arcangeli A, Amedei A. The increase of endothelial progenitor cells in the peripheral blood: a new parameter for detecting onset and severity of sepsis. Int J Immunopathol Pharmacol 21: 697-705, 2008.
5. Beck GC, Rafat N, Yard B, Hanusch C. The role of endothelial progenitor cells in sepsis. Anaesthesist 56: 423-428, 2007.
6. Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG. Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 18: 2486-2496, 2007.
7. Cribbs SK, Martin GS, Rojas M. Monitoring of endothelial dysfunction in critically ill patients: the role of endothelial progenitor cells. Curr Opin Crit Care 14: 354-360, 2008.
8. Csoka A, Frost G, Staern R. The hyaluronidase-like genes in the human and mouse genomes. Matrix Biol 20: 499-508, 2001.
9. Doi K, Leelahavanichkul A, Yuen PS, Star RA. Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest 119: 2868-2878, 2009.
10. Drake T, Cheng J, Chang A, Taylor F. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 142: 1458-1470, 1993.
11. Gerecht S, Burdick L, Ferreira S, Townsend S, Langer R, Vunjak- Novakovic G. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci USA, 104: 11298-11303, 2007.
12. Hatzopoulos AK, Folkman J, Vasile E, Eiselen GK, Rosenberg RD. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development 125: 1457-1468, 1998.
13. Hill J, Zalos G, Halcox J, Schenke W, Waclawiw M, Quyyumi A, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600, 2003.
14. Hohenstein B, Kuo MC, Addabbo F, Yasuda K, Ratliff B, Schwarzenberger C, Eckardt KU, Hugo CP, Goligorsky MS. Enhanced progenitor cell recruitment and endothelial repair after selective endothelial injury of the mouse kidney. Am J Physiol Renal Physiol 298: F1504- F1514, 2010.
15. Ingram D, Caplice N, Yoder M. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 106: 1525-1531, 2005.
16. Jiang D, Liang J, Noble PW. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 23: 435-461, 2007.
17. Langenberg C, Wan L, Egi M, May C, Bellomo R. Renal blood flow in experimental septic acute kidney injury. Kidney Int 69: 1996-2002, 2006.
18. Laurent T, Fraser J. The properties and turnover of hyaluronic acid. Ciba Found Symp 124: 9-29, 1986.
19. Laurent T, Fraser J. Catabolism of hyaluronic acid. In: Degradation of Bioactive Substances: Physiology and Pathophysiology, edited by Henriksen JH. Boca Raton, FL: CRC, 1991, p. 249-265.
20. Mao M, Wang SN, Lv XJ, Wang Y, Xu JC. Intravenous delivery of bone marrow-derived endothelial progenitor cells improves survival and attenuates lipopolysaccharide-induced lung injury in rats. Shock 34: 196-204, 2010.
21. Mayr RB, Spiel AO, Leitner JM, Firbas C, Sieghart W, Jilma B. Effects of low dose endotoxemia on endothelial progenitor cells in humans. Atherosclerosis 195: e202-e206, 2007.
22. Messmer U, Briner V, Pfeilschifter J. Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. Kidney Int 55: 2322-2337, 1999.
23. Muto J, Yamasaki K, Taylor K, Gallo R. Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS. Mol Immunol 47: 449-456, 2009.
24. Mutunga M, Fulton B, Bullock R, Batchelor A, Gascoigne A, Gillespie JI, Baudouin SV. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med 163: 195-200, 2001.
25. Németh K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, Mezey E. Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15: 42-49, 2009.
26. Pula G, Mayr U, Evans C, Prokopi M, Vara D, Yin X, Astroulakis Z, Xiao Q, Hill J, Xu Q, Mayr M. Proteomics identifies thymidine phosphorylase as a key regulator of the angiogenic potential of colony-forming units and endothelial progenitor cells in culture. Circ Res 104: 32-40, 2009.
27. Rafat N, Hanusch C, Brinkkoetter PT, Schulte J, Brade J, Zijlstra JG, van der Woude FJ, van Ackern K, Yard BA, Beck GC. Increased circulating endothelial progenitor cells in septic patients: correlation with survival. Crit Care Med 35: 1677-1684, 2007.
28. Ratliff BB, Ghaly T, Brudnicki P, Yasuda K, Rajdev M, Bank M, Mares J, Hatzopoulos AK, Goligorsky MS. Endothelial progenitors encapsulated in bioartificial niches are insulated from systemic cytotoxicity and are angiogenesis competent. Am J Physiol Renal Physiol 299: F178-F186, 2010.
29. Remick D, Newcomb D, Bolgos G, Call D. Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13: 110-116, 2000.
30. Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 32: 1825-1831, 2004.
31. Spiel AO, Mayr FB, Leitner JM, Firbas C, Sieghart W, Jilma B. Simvastatin and rosuvastatin mobilize endothelial progenitor cells but do not prevent their acute decrease during systemic inflammation. Thromb Res 123: 108-113, 2008.
32. Sun L, Feusi E, Sibalic A, Beck-Schimmer B, Wuthrich R. Expression profile of hyaluronidase mRNA transcripts in the kidney and in renal cells. Kidney Blood Press Res 21: 413-418, 1998.
33. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438, 1999.
34. Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289: F31-F42, 2005.
35. Tsaganos T, Giamarellos-Bourboulis EJ, Kollias S, Zervakis D, Karagianni V, Pelekanou A, Tampaki EC, Kontogiorgi M, Koroneos A, Drakoulis N, Armaganidis A, Roussos C, Giamarellou H. Kinetics of progenitor hematopoietic stem cells in sepsis: correlation with patients' survival? BMC Infect Dis 6: 142-148, 2006.
36. Vallet B, Wiel E. Endothelial cell dysfunction and coagulation. Crit Care Med 29: S36-S41, 2001.
37. Wu L, Gokden N, Mayeux P. Evidence for the role of reactive nitrogen species in polymicrobial sepsis-induced renal peritubular capillary dysfunction and tubular injury. J Am Soc Nephrol 18: 1807-1815, 2007.
38. Wu L, Tiwari MM, Messer KJ, Holthoff JH, Gokden N, Brock RW, Mayeux P. Peritubular capillary dysfunction and renal tubular epithelial stress following lipopolysaccharide administration in mice. Am J Physiol Renal Physiol 292: F261-F268, 2007.
39. Xu J, Woods CR, Mora AL, Joodi R, Brigham KL, Iyer S, Rojas M. Prevention of endotoxin-induced systemic response by bone marrowderived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol 293: L131-L141, 2007.
40. Yamada M, Kubo H, Kobayashi S, Ishizawa K, Numasaki M, Ueda S, Suzuki T, Sasaki H. Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J Immunol 172: 1266-1272, 2004.
41. Yamamoto K, Loskutoff D. Fibrin deposition in tissues from endotoxintreated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest 97: 2440-2451, 1996.
42. Yanada M, Kojima T, Ishiguro K, Nakayama Y, Yamamoto K, Matsushita T, Kadomatsu K, Nishimura M, Muramatsu T, Saito H. Impact of antithrombin deficiency in thrombogenesis: lipopolysaccharide and stress-induced thrombus formation in heterozygous antithrombindeficient mice. Blood 99: 2455-2458, 2002.
43. Yasuda H, Yuen P, Hu X, Zhou H, Star RA. Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int 69: 1535-1542, 2006.
44. Yasuda K, Park HC, Ratliff B, Addabbo F, Hatzopoulos AK, Chander P, Goligorsky MS. Adriamycin nephropathy-a failure of endothelial progenitor cell-induced repair. Am J Pathol 176: 1685-1695, 2010.
45. Yoder M, Mead L, Prater D, Krier T, Mroueh K, Li F, Krasich R, Temm C, Prchal J, Ingram D. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cells principals. Blood 109: 1801-1809, 2007.
46. Zhao B, Bowden RA, Stavchansky SA, Bowman PD. Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA micro-arrays. Am J Physiol Cell Physiol 281: C1587-C1595, 2001.